Kedem Pharmaceuticals Inc.
company.status.inactiveCIK 1376228fmd_1NTG5B0PHMVQ9XYZB53R7PSZ7RServices · Services-Allied To Motion Picture ProductionTemplate: Standard
Coverage: Jun 01, 2008 to Nov 30, 2012, 12 periods
Latest annual · FY2012
Millions- Operating income
- (2)
- Net income
- (6)
Latest quarter · Q2 FY2013
Millions- Operating income
- (0)
- Net income
- (1)
Kedem Pharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.4 million | -$2 million | 10-K 2012-08-28 · proof | |
| Net income | -$5.9 million | -$4.2 million | 10-K 2012-08-28 · proof | |
| Cash from operating activities | -$1.9 million | -$1.4 million | 10-K 2012-08-28 · proof | |
| Total assets | $1.1 million | $2.7 million | -58.9% | 10-K 2012-08-28 · proof |
| Total liabilities | $4.4 million | $2.1 million | +106.6% | 10-K 2012-08-28 · proof |
| Cash and cash equivalents | $294,936 | $1.5 million | -80.1% | 10-K 2012-08-28 · proof |
- What was Kedem Pharmaceuticals Inc.'s operating income in fiscal 2012?
- Kedem Pharmaceuticals Inc. reported operating income of -$2.4 million for fiscal 2012 (the year ended May 31, 2012), against -$2 million the year before. Source: the 10-K filed with the SEC on Aug 28, 2012. SEC
- What was Kedem Pharmaceuticals Inc.'s net income in fiscal 2012?
- Kedem Pharmaceuticals Inc. reported net income of -$5.9 million for fiscal 2012 (the year ended May 31, 2012), against -$4.2 million the year before. Source: the 10-K filed with the SEC on Aug 28, 2012. SEC
- What was Kedem Pharmaceuticals Inc.'s cash from operating activities in fiscal 2012?
- Kedem Pharmaceuticals Inc. reported cash from operating activities of -$1.9 million for fiscal 2012 (the year ended May 31, 2012), against -$1.4 million the year before. Source: the 10-K filed with the SEC on Aug 28, 2012. SEC
- What are Kedem Pharmaceuticals Inc.'s total assets?
- As of May 31, 2012, Kedem Pharmaceuticals Inc. reported total assets of $1.1 million, against $2.7 million a year earlier (-58.9%). Source: the 10-K filed with the SEC on Aug 28, 2012. SEC
- What are Kedem Pharmaceuticals Inc.'s total liabilities?
- As of May 31, 2012, Kedem Pharmaceuticals Inc. reported total liabilities of $4.4 million, against $2.1 million a year earlier (+106.6%). Source: the 10-K filed with the SEC on Aug 28, 2012. SEC
- What are Kedem Pharmaceuticals Inc.'s cash and cash equivalents?
- As of May 31, 2012, Kedem Pharmaceuticals Inc. reported cash and cash equivalents of $294,936, against $1.5 million a year earlier (-80.1%). Source: the 10-K filed with the SEC on Aug 28, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1376228&period_type=annual&limit=5"Information only, not investment advice.